Insight Genetics Inc

"We believe Insight TNBCtype can further enable clinical trial testing and ultimately become the standard of care for TNBC patients bringing TNBC into the age of precision medicine.” - Eric Dahlhauser, Insight Genetics CEO insightgenetics.com/news

Did you know molecular profiling is integral to developing treatments for #TNBC? Learn more about triple negative breast cancer here: bit.ly/2SpmjPr #moleculardiagnostics #breastcancer #precisionmedicine

Identifying #TNBC biomarkers can advance targeted drug development. Insight TNBCtype categorizes TNBC tumors into molecular subtypes. bit.ly/2PfSWgw #targetedtherapies #breastcancer

Thank you @SABCSSanAntonio for a wonderful conference highlighting some of the most important work in cancer diagnostics and treatment. Already looking forward to 2019! #SABCS18 #breastcancer #bcsm #TNBC

Thanks Dr. Sharma from @KUMedCenter for explaining the longterm outcomes of #TNBC for adjuvant AC chemotherapy patients. #SABCS18 #bcsm bit.ly/2zC4uWg

Important insight from Dr. Musuda from @MDAndersonNews on #TNBC tumor samples at #SABCS18. bit.ly/2zC4uWg

Check out Poster #P4-08-06 on the impact of molecular subtypes on long-term outcomes in #TNBC patients treated with adjuvant AC #chemotherapy #SABCS18 #TNBC #targetedtherapies #bcsm

The @TNBCFoundation hosted a meeting at the San Antonio Breast Cancer Symposium dedicated exclusively to TNBC. An update from the #SABCS is now available online for our TNBC community. Read more at: ow.ly/HVjj30mTtWV

Check out abstracts #P4-02-05 and #P4-08-06 about #TNBC at tomorrow's Poster Sessions from 7-9 am in Hall 1! #SABCS18 #bcsm

Are you at #SABCS18? Come to Poster Session 4 on 12/7 to learn how we're advancing #TNBC diagnostics and therapeutics

In many ways, #TNBC is the last frontier in breast cancer, as there are currently no targeted therapeutics available for this population. We’re working to change that with Insight TNBCtype™. bit.ly/2PfSWgw #targetedtherapy #precisionmedicine bit.ly/2zC4uWg

@teamoncology about Insight TNBCtype - “The opportunity to improve the treatment and lives of TNBC patients with a diagnostic that is CLIA-validated and commercially positioned to support clinical trials is a major step forward.” #TNBC #cancerdiagnostics insightgenetics.com/news

Excited for the #SABC18 Poster Session 4 on Friday. Insight TNBCtype will be included in two posters - one from @KUMedCenter and one from @MDAndersonNews. #bcsm #targetedtherapies #TNBC

Insight TNBCtype has the potenial to accelerate #clinicalresearch and advance #targetedtherapies for triple negative breast cancer. #TNBC #bcsm bit.ly/2PfSWgw

@SWOG investigators present three breast cancer studies at #SABCS18. Public-powered cancer research! @theNCI #BeatCancerWithResearch bit.ly/2SrbdJF via @SWOG @EurekAlert

We're following @MedscapeOnc for regular news updates from #SABC18. #bcsm #oncology medscape.com/viewcollection…

Up next - our session on late recurrence in ER+ breast cancer - w/ M Ellis, M Dowsett, L Chodash #SABCS18

We are dedicated to improving the lives of cancer patients through advanced molecular diagnostics that enable precision cancer care. We're ready for this year's #SABCS18! #precisionmedicine #bcsm #TNBC

Insight TNBCtype is a new test that categorizes triple negative breast cancer tumors into distinct molecular subtypes. #breastcancer #bcsm #TNBC bit.ly/2PfSWgw

Insight Genetic contributed to two posters at #SABCS18 that showcase findings from the use of Insight TNBCtype! Stop by poster session #4 on Friday! #TNBC #bcsm